Heather Cohen, Ph.D., et al. Preclinical Evaluation of JTX-8064, an Anti-LILRB2 Antagonist Antibody, for Reprogramming Tumor-Associated Macrophages. Presented at AACR Annual Meeting, April 3, 2019.